Science Fair Project Encyclopedia
Co-amoxiclav
Co-amoxiclav is the British Approved Name, in the British Pharmacopoeia, for the combination antibiotic containing amoxicillin and clavulanic acid. This name, unlike co-trimoxazole, has not been widely adopted internationally and the combination product is usually referred to by various names such as amoxicillin with clavulanic acid or amoxicillin+clavulanate or simply by the trade name. Co-amoxiclav is currently marketed by GlaxoSmithKline under the trade name Augmentin®.
The combination of amoxicillin, a β-lactam antibiotic; with clavulanic acid, a β-lactamase inhibitor; results in an antibiotic with an increased spectrum of action and restored efficacy against β-lactamase producing amoxicillin-resistant bacteria.
Dosage
- Co-amoxiclav sensitive organisms
| ADULTS: | ||||
| PRODUCT | UPPER RESPIRATORY TRACT INFECTIONS | LOWER RESPIRATORY TRACT INFECTIONS | URINARY TRACT INFECTIONS | SKIN AND SOFT TISSUE INFECTIONS |
| AUGMENTIN 375 | 1 - 2 tablets 8 hourly | 1 - 2 tablets 8 hourly | 1 - 2 tablets 8 hourly | 1 - 2 tablets 8 hourly |
| AUGMENTIN 625 | 1 tablet 8 hourly | 1 tablet 8 hourly | 1 tablet 8 hourly | 1 tablet 8 hourly |
| AUGMENTIN BD | 1 tablet 12 hourly | 1 tablet 12 hourly | 1 tablet 12 hourly | 1 tablet 12 hourly |
03-10-2013 05:06:04
The contents of this article is licensed from www.wikipedia.org under the GNU Free Documentation License. Click here to see the transparent copy and copyright details
The contents of this article is licensed from www.wikipedia.org under the GNU Free Documentation License. Click here to see the transparent copy and copyright details